ALTERITY THERAPEUTICS-ADR (ATHE)
US02155X2053 - ADR
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 123.46K | 16.44K | 2.50K | 20.68K | 17.12K | |||
| Operating Expenses | 14.40M | 14.64M | 15.96M | 15.39M | 13.93M | |||
| Research and Development | 11.80M | 13.20M | 14.75M | 12.28M | 10.10M | |||
| Selling, General, and Administrative Expenses | 4.38M | 5.22M | 5.82M | 7.16M | 3.67M | |||
| Operating Income | -14.28M | -14.62M | -15.95M | -15.37M | -13.91M | |||
| Interest Income/Expense | 464.15K | 917.65K | 2.72M | -297.11K | 333.06K | |||
| Other Income/Expense | N/A | 2.10K | 454.12K | 213.24K | N/A | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | 145.63K | 122.73K | |||
| Income Before Taxes | -12.28M | -13.70M | -12.78M | -15.31M | -13.46M | |||
| Income Tax | 560.00 | 104.46K | 70.01K | 0.00 | 0.00 | |||
| Net Income | -12.28M | -13.81M | -12.85M | -15.31M | -13.46M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.42 | -1.63 | -1.53 | -2.59 | -4.31 | |||
| Statistics | ||||||||
| Profit Margin | -9947.97% | -83981.27% | -513882.40% | -74029.74% | -78602.80% | |||
| Operating Profit Margin | -11563.13% | -88940.45% | -638144.40% | -74328.34% | -81265.07% | |||
All data in AUD